Cargando…

Neurological update: MOG antibody disease

Myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOG-AD) is now recognised as a nosological entity with specific clinical and paraclinical features to aid early diagnosis. Although no age group is exempt, median age of onset is within the fourth decade of life, with optic neuritis being t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wynford-Thomas, Ray, Jacob, Anu, Tomassini, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Neurological Update
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469662/ https://www.ncbi.nlm.nih.gov/pubmed/30569382 http://dx.doi.org/10.1007/s00415-018-9122-2

Ejemplares similares

Neurological update: dizziness
por: Kaski, Diego
Publicado: (2020)

Neurological updates: neurological complications of CAR-T therapy
por: Tallantyre, Emma C., et al.
Publicado: (2020)

Neurological update: neuroimaging in dementia
por: Rittman, Timothy
Publicado: (2020)

Neurological update: COVID-19
por: Ren, A. L., et al.
Publicado: (2021)

Neurological update: hereditary neuropathies
por: Kramarz, Caroline, et al.
Publicado: (2022)

Neurological update: neuro-otology 2023
por: Halmágyi, Gábor M., et al.
Publicado: (2023)

Neurological update: use of cardiac troponin in patients with stroke
por: Scheitz, Jan F., et al.
Publicado: (2020)

Neurological update: structural and functional imaging in epilepsy surgery
por: Yoganathan, Katie, et al.
Publicado: (2023)

Predictors of relapse in MOG antibody associated disease: a cohort study
por: Huda, Saif, et al.
Publicado: (2021)

Neurological update: gliomas and other primary brain tumours in adults
por: Brandner, Sebastian, et al.
Publicado: (2017)

Neurological update: non-motor symptoms in atypical parkinsonian syndromes
por: Ananthavarathan, Piriyankan, et al.
Publicado: (2023)

Neurological update: consult the neurosurgical oracle for a standard operating procedure
por: Goedemans, Taco, et al.
Publicado: (2022)

Susac syndrome: neurological update (clinical features, long-term observational follow-up and management of sixteen patients)
por: Bose, Smriti, et al.
Publicado: (2023)

Neurological update: treatment escalation in multiple sclerosis patients refractory to fingolimod—potentials and risks of subsequent highly active agents
por: Korsen, Melanie, et al.
Publicado: (2022)

Investigating the association between neoplasms and MOG antibody-associated disease
por: Trentinaglia, Milena, et al.
Publicado: (2023)

Cerebrovascular manifestations in hematological diseases: an update
por: Ferro, José M., et al.
Publicado: (2021)

Update cerebellum and cognition
por: Jacobi, Heike, et al.
Publicado: (2021)

Management of functional neurological disorder
por: Gilmour, Gabriela S., et al.
Publicado: (2020)

Spinocerebellar ataxia: an update
por: Sullivan, Roisin, et al.
Publicado: (2018)

Recent developments in MOG-IgG associated neurological disorders
por: Hegen, Harald, et al.
Publicado: (2020)

POEMS syndrome: clinical update
por: Brown, Rachel, et al.
Publicado: (2018)

An update on genetic frontotemporal dementia
por: Greaves, Caroline V., et al.
Publicado: (2019)

Diagnosing vestibular hypofunction: an update
por: Starkov, Dmitrii, et al.
Publicado: (2020)

Update on benign paroxysmal positional vertigo
por: Kim, Hyo-Jung, et al.
Publicado: (2020)

Interpretation of vaccine associated neurological adverse events: a methodological and historical review
por: Cauchi, Marija, et al.
Publicado: (2021)

An update on the diagnosis and management of the polyneuropathy of POEMS syndrome
por: Cerri, Federica, et al.
Publicado: (2018)

Myasthenia gravis: a clinical-immunological update
por: Binks, Sophie, et al.
Publicado: (2015)

An update on migraine: current understanding and future directions
por: Puledda, Francesca, et al.
Publicado: (2017)

Focal task specific dystonia: a review and update
por: Stahl, Christine M., et al.
Publicado: (2016)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges
por: Al-Ani, Abdullah, et al.
Publicado: (2023)

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults
por: Parrotta, Erica, et al.
Publicado: (2020)

An update on advances in magnetic resonance imaging of multiple system atrophy
por: Chelban, Viorica, et al.
Publicado: (2018)

Navigating migraine care through the COVID-19 pandemic: an update
por: Angus-Leppan, Heather, et al.
Publicado: (2021)

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
por: Hochmeister, Sonja, et al.
Publicado: (2020)

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
por: Hyun, Jae-Won, et al.
Publicado: (2020)

An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention
por: Chelban, Viorica, et al.
Publicado: (2020)

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
por: Manzano, Giovanna S., et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
por: Cross, Helen, et al.
Publicado: (2021)

A case report of neurosyphilis coexisting with a positive MOG antibody manifested as optic neuritis
por: Shi, Min, et al.
Publicado: (2023)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South China: Clinical Features, Treatments, Influencing Factors, and Outcomes
por: Mao, Leilei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u7fi744hue80s7h9ki4m9vget6